ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0390

Radiographic Assessment in Juvenile Spondyloarthritis: Evaluating the axJSpA Criteria Using Radiographs Alone Versus MRI

David M. Biko1, Nancy A. Chauvin2, Michael Francavilla3, Nele Herregods4, Walter P. Maksymowych5, Robert G. W. Lambert6, Timothy Brandon1, Ozgur Kasapcopur7, Mehmet YILDIZ8, Hemalatha Srinivasalu9 and Pamela Weiss10, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2The Cleveland Clinic, Hummelstown, PA, 3Department of Pediatric Radiology, Children’s Hospital Philadelphia, Philadelphia, PA, 4Ghent University Hospital, Ghent, Belgium, 5Department of Medicine, University of Alberta, 568 Heritage Building, Edmonton, AB, Canada, 6University of Alberta, Department of Radiology & Diagnostic Imaging, Edmonton, AB, Canada, 7Istanbul University-Cerrahpasa, Cerrahpasa Medical School, istanbul, Turkey, 8Istanbul University-Cerrahpasa Department of Pediatric Rheumatology, Istanbul, Turkey, 9Children's National Hospital, Washington, DC, 10Childrens Hospital of Philadelphia, Philadelphia, PA

Meeting: ACR Convergence 2025

Keywords: classification criteria, Magnetic resonance imaging (MRI), Pediatric rheumatology, spondyloarthritis, X-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0387–0429) Pediatric Rheumatology – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Radiographs are neither sensitive nor reliable for assessing axial disease in juvenile spondyloarthritis (JSpA), though they are still used in some settings due to limited access to magnetic resonance imaging (MRI). The recently validated axial JSpA (axJSpA) classification criteria include inflammatory and structural imaging domains. When both imaging modalities are available, MRI findings are prioritized over radiographic data in the structural domain. This study evaluated the performance of the axJSpA criteria when using pelvic radiographs alone and compared these results with those based on MRI.

Methods: We conducted a retrospective analysis of an international cohort of patients with JSpA and symptom onset before age 18. All participants underwent anteroposterior (AP) pelvic radiography and dedicated pelvic MRI during axial disease evaluation. A centralized panel independently reviewed cases for unequivocal sacroiliitis: structural lesions on radiograph and both inflammatory and/or structural lesions on MRI typical of axial disease (Table 1). Imaging criteria were considered met when the majority of raters agreed. Agreement between radiograph- and MRI-defined structural lesions was assessed using Cohen’s kappa coefficient. For each subject, fulfillment of the axJSpA criteria was assessed using MRI data and radiographic data alone, in addition to non-imaging domains. For the assessment of radiographic data alone, the inflammatory lesions on imaging domain for criteria defaulted to a score of “0”.

Results: A total of 137 subjects (59.1% male; median age 14.3 years) were included. Imaging criteria were met in 40 (29.2%) cases for MRI-defined inflammatory lesions, 33 (24.1%) for MRI-defined structural lesions, and 29 (21.2%) for radiographic sacroiliitis. Agreement between MRI- and radiograph-defined structural lesions yielded a kappa coefficient of 0.54, indicating moderate concordance (Table 2). Using MRI data, 40 subjects met axJSpA classification criteria, compared to 12 using radiographic data alone. Relying on radiographic findings altered classification status in 32 (23.4%) subjects, with 2 additional cases meeting criteria and 30 cases no longer fulfilling them (Figure 1).

Conclusion: Although pelvic radiographs moderately align with MRI in identifying structural lesions, reliance on radiographic findings alone can misclassify a subset of patients under the axJSpA criteria. These findings underscore the importance of obtaining and prioritizing MRI for accurate classification and assessment of axial disease in JSpA when available. Nevertheless, in settings where MRI is unavailable, the criteria still perform reasonably when based solely on radiographic findings, supporting their utility in resource-limited contexts.

Supporting image 1Table 1. Validated definitions for axJSpA Imaging Classification Criteria.

Supporting image 2Table 2. Agreement between radiograph- and MRI-defined structural lesions.

Supporting image 3Figure 1. Re-classification of axJSpA status using MRI and radiograph as sources for imaging domain weighting. Patient classification by axJSpA status using the different imaging modality combinations were AxJSpA+ (MRI)/AxJSpA+ (Radiograph): n=10, AxJSpA+ (MRI)/AxJSpA- (Radiograph): n=30, AxJSpA- (MRI)/AxJSpA+ (Radiograph): n=2, and AxJSpA- (MRI)/AxJSpA- (Radiograph): n=95. Using radiograph-only data excluded scoring from the inflammatory lesions domain. AxJSpA+ = axial juvenile spondyloarthritis classification criteria met; AxJSpA- = axial juvenile spondyloarthritis classification criteria not met.


Disclosures: D. Biko: None; N. Chauvin: None; M. Francavilla: None; N. Herregods: None; W. Maksymowych: AbbVie, 2, 5, 6, BMS, 2, 5, 6, Boehringer-Ingelheim, 2, Celgene, 2, Chief Medical Officer for CARE ARTHRITIS, 4, Eli Lilly, 2, 5, 6, Galapagos, 2, 5, 6, Janssen, 2, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, UCB, 2, 5, 6; R. Lambert: AbbVie, 2, CARE Arthritis and Image Analysis Group, 2; T. Brandon: None; O. Kasapcopur: None; M. YILDIZ: None; H. Srinivasalu: Otsuka, 3; P. Weiss: Bristol-Myers Squibb(BMS), 2, Pfizer, 1.

To cite this abstract in AMA style:

Biko D, Chauvin N, Francavilla M, Herregods N, Maksymowych W, Lambert R, Brandon T, Kasapcopur O, YILDIZ M, Srinivasalu H, Weiss P. Radiographic Assessment in Juvenile Spondyloarthritis: Evaluating the axJSpA Criteria Using Radiographs Alone Versus MRI [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/radiographic-assessment-in-juvenile-spondyloarthritis-evaluating-the-axjspa-criteria-using-radiographs-alone-versus-mri/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/radiographic-assessment-in-juvenile-spondyloarthritis-evaluating-the-axjspa-criteria-using-radiographs-alone-versus-mri/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology